The CSL share price is up 32% this year: Will there be even more gains in 2019?

It has been another positive year for the CSL Limited (ASX: CSL) share price.

If the biotherapeutics company’s shares don’t slide lower on Monday, it will mean they finish 2018 with a gain of at least 32%.

Is it too late to buy CSL shares?

Although CSL’s shares have rallied hard this year and trade at a premium to the market average, I don’t believe it is too late to make an investment.

While I wouldn’t necessarily expect another 32% gain next year, I think CSL’s shares are more than capable of being market-beaters again in 2019 due to the strength of its core business and growing plasma collection network.

I’m not alone in thinking that CSL has market-beating potential next year.

A recent note out of the Macquarie Group Ltd (ASX: MQG) equities desk reveals that its analysts retained their outperform rating and $230.00 price target following its R&D day.

This price target implies potential upside of approximately 23% over the next 12 months.

According to the note, the broker is positive on CSL’s near term growth prospects thanks to positive contributions from products that have been commercialised in recent years.

In addition to this, Macquarie believes that its growth could be given a boost from a number of products under development and early stage opportunities.

The former includes the FDA submission for a 21-day dose for Idelvion, the phase 3 study of CSL842, and expanding Hizentra indications.

Should you invest?

I think Macquarie is spot on with its assessment and feel now would be a good time to consider picking up CSL shares.

Other options in the healthcare sector that I think also have the potential to be market beaters are hearing solutions company Cochlear Limited (ASX: COH) and medical device company ResMed Inc (ASX: RMD).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!